PDL1 expression is an independent prognostic factor in localized GIST.
about
PDL1 expression in inflammatory breast cancer is frequent and predicts for the pathological response to chemotherapy.Prognostic and Clinicopathological Value of Programmed Death Ligand-1 in Breast Cancer: A Meta-Analysis.Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma.Prognostic value of PDL1 expression in pancreatic cancerPD-L1, Galectin-9 and CD8+ tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma.Promising novel therapeutic approaches in the management of gastrointestinal stromal tumors."Wild type" GIST: Clinicopathological features and clinical practice.Pharmacological therapies for Liposarcoma.Current status of immunotherapy for gastrointestinal stromal tumor.Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients.Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells.Sensitive detection of PD-L1 expression on circulating epithelial tumor cells (CETCs) could be a potential biomarker to select patients for treatment with PD-1/PD-L1 inhibitors in early and metastatic solid tumors.New targets and therapies for gastrointestinal stromal tumors.High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients.PD-L1 expression associated with worse survival outcome in malignant pleural mesothelioma.Role of immune microenvironment in gastrointestinal stromal tumours.PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors.Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation.PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas.Programmed death 1 expression in the peritumoral microenvironment is associated with a poorer prognosis in classical Hodgkin lymphoma.CMTM6 stabilizes PD-L1 expression and refines its prognostic value in tumors.Prognostic Factors for Checkpoint Inhibitor Based Immunotherapy: An Update With New Evidences
P2860
Q35955369-31B180A6-F006-48F0-8321-254B6D41A6FDQ36030084-3BCD22F2-5EB6-425D-BAD4-FF61E2E7175DQ37477267-40B579E9-A290-400A-BAE9-FBA6B3C6FDADQ37687595-D437ECED-52BF-4036-BB08-3B22259A1233Q37705021-E8E62620-5806-4638-A133-837F0DFE8F4DQ38823874-64E94CA8-3360-42E9-846A-F10D4014F915Q38900208-4A4B58C6-192D-4304-A35B-2398B578D1ADQ38991731-4178CDEE-6C25-4EEE-AC47-C14B7F6439D5Q39130013-38B64AE5-7BEB-4A71-9742-D0548CAABECDQ39641921-23B43A42-BD3E-4169-88C6-3CCBD528F993Q40583098-9F3503F3-A57A-4020-9EB5-C082D9FE79E0Q42700740-38A3FB65-2115-4954-8887-3922FA21E323Q47432725-4D882C9F-CD28-4199-B027-E09CDF99CB53Q47576215-3D9A1949-126E-4A3C-B223-797791D66DBCQ47654312-85EC9A4A-25B0-41E5-B595-E14C8DF88FC4Q47856440-DF702700-B87F-4B0C-8333-4166C0CECC4FQ49150658-7EE7D0C9-1A46-41E4-AA4A-7ED5D6BC6C57Q52602401-1BD1B573-88D8-486F-B8C1-C23F7C26E562Q52682430-F1364B89-40D3-4D68-AE82-B7482B1B0877Q53245652-26B5B53A-778C-4852-A81D-C3F4620B1A04Q54981008-100A3534-D41E-45EE-AA53-5A7DC7C8466DQ57191808-0816AA7C-AC10-41CD-9C0A-93FA3485BAAE
P2860
PDL1 expression is an independent prognostic factor in localized GIST.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
PDL1 expression is an independent prognostic factor in localized GIST.
@ast
PDL1 expression is an independent prognostic factor in localized GIST.
@en
type
label
PDL1 expression is an independent prognostic factor in localized GIST.
@ast
PDL1 expression is an independent prognostic factor in localized GIST.
@en
prefLabel
PDL1 expression is an independent prognostic factor in localized GIST.
@ast
PDL1 expression is an independent prognostic factor in localized GIST.
@en
P2093
P2860
P50
P1433
P1476
PDL1 expression is an independent prognostic factor in localized GIST.
@en
P2093
Daniel Birnbaum
François Bertucci
Pascal Finetti
P2860
P304
P356
10.1080/2162402X.2014.1002729
P577
2015-02-03T00:00:00Z